| 摘要 |
What are disclosed are prostacylin PGI2 analogs of the formula <IMAGE> having a more specific or longer lasting pharmacological action than PGI2, methods of making these analogs; and methods and pharmaceutical preparations for inhibiting blood platelet aggregation, for treating hypertension, for the treatment or prophylaxis of gastrointestinal ulcers, and for the treatment of asthma. |
